From: Phlebovirus seroprevalence in Austrian Army personnel returning from missions abroad
1:10 | 1:20 | 1:40 | 1:80 | 1:100 | 1:320 | 1:1000 | Total | ||
---|---|---|---|---|---|---|---|---|---|
IgG | Without prior mission | 8/267 (2.99%) | 3/267 (1.12%) | 4/267 (1.50%) | 4/267 (1.50%) | 3/267 (1.12%) | 9/267 (3.37%) | – | 31/267 (11.6%) |
BIH | – | 1/61 (1.64%) | 1/61 (1.64%) | 2/61 (3.28%) | 3/ 61 (4.92%) | – | – | 7/61 (11.47%) | |
Kosovo | 23/261 (8.81%) | 3/261 (1.15%) | 11/261 (4.21%) | 3/261 (1.15%) | 6/261 (2.30%) | 7/261 (2.68%) | 1/261 (0.38%) | 54/261 (20.69%) | |
Syria | 3/101 (2.97%) | 2/101 (1.98%) | 4/101 (3.96%) | 1/101 (0.99%) | 3/ 101 (2.97%) | 5/101 (4.95%) | – | 18/101 (17.82%) | |
Lebanon | 1/63 (1.59%) | 1/63 (1.59%) | – | 1/63 (1.59%) | 3/63 (4.76%) | – | 3/63 (4.76%) | 9/63 (14.28%) | |
IgMa | Without prior mission | 2/31 (6.45%) | 3/31 (9.68%) | 3/31 (9.68%) | 2/31 (6.45%) | – | – | 10/31 (32.25%) | |
BIH | – | – | – | – | – | – | – | 0/7 (0.00%) | |
Kosovo | 5/54 (9.26%) | 5/54 (9.26%) | – | 2/54 (3.70%) | 4/54 (7.41%) | – | – | 16/54 (29.63%) | |
Syria | – | 1/18 (5.55%) | – | 1/18 (5.55%) | 1/18 (5.55%) | – | – | 3/18 (16.67%) | |
Lebanon | – | 1/9 (11.11%) | – | – | – | – | – | 1/9 (11.11%) |